2-(5-Methyl-2-furanyl)-3-piperidinol

Metabolite details

Identifier

KHCYBVSLKKTRRJ-UHFFFAOYSA-N

InChI Key

KHCYBVSLKKTRRJ-UHFFFAOYSA-N

IUPAC name

2-(5-methyluran-2-yl)piperidin-3-ol

Preferred name

2-(5-Methyl-2-furanyl)-3-piperidinol

INN name

—

Synonym

—

ChEBI

CHEBI:173514

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• G1_PBS_vs_G2_DSS
• Control_vs_CSD
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d